NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.

NCT06899633

Active Not RecruitingN/A

Sponsor: AstraZeneca

Conditions: Description of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan, Description of the Course of SLE in Patients in the Republic of Kazakhstan, Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of Kazakhstan

Countries: Kazakhstan

Multicenter, observational, descriptive study of the diagnosis, course and treatment of patients with SLE in routine practice in Kazakhstan: a registry study with retrospective and prospective components.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria

* Men and women aged 18 years and older with a verified diagnosis of SLE
* Patient signed and dated written informed consent form (ICF) by ICH GCP and local legislation prior to inclusion in the study for the prospective observational group.

Exclusion Criteria

* Absence of a signed consent form (ICF) in patients
* Cognitive impairments that hinder understanding the study objectives and completing questionnaires
* Participation in any randomized controlled clinical trial within 3 months prior to inclusion or during participation in this study.

Locations (12)

Aktobe, Kazakhstan
Almaty, Kazakhstan
Almaty, Kazakhstan
Almaty, Kazakhstan
Almaty, Kazakhstan
Astana, Kazakhstan
Pavlodar, Kazakhstan
Semey, Kazakhstan
Shymkent, Kazakhstan
Shymkent, Kazakhstan
Taldykorgan, Kazakhstan
Taraz, Kazakhstan